Guidelines for Insulin Therapy in Canadian Diabetes Care

In past years, insulin has been the backbone of Type 1 and Type 2 diabetes management in Canada. Recognizing the pivotal role that insulin plays in maintaining glucose control, the Canadian Diabetes Association (CDA) has laid out specific guidelines for insulin therapy. Within these protocols, the use of Canadian insulin has been emphasized.

According to the guidelines, insulin therapy should be initiated as soon as possible after the diagnosis of Type 1 diabetes is confirmed. Insulin dosages should be adjusted based on individual patient needs, taking into consideration factors such as the patient’s weight, lifestyle, and the stage of the disease.

The CDA also provides specific recommendations regarding types of insulin to be used. For instance, rapid-acting insulins such as insulin lispro, insulin aspart, and insulin glulisine should be used for mealtime insulin, whereas long-acting insulins such as insulin detemir and insulin glargine should be used for basal insulin.

Insulin Usage Trends in Type 1 and Type 2 Diabetes in Canada

In recent years, there has been a significant change in the insulin usage patterns among Canadian diabetics. This shift is characterized by an increased use of insulin pump therapy and continuous glucose monitoring (CGM) systems. Their usage is strongly encouraged due the associated benefits including better blood glucose control, fewer diabetes-related complications, and improved quality of life.

Another trend to note is the increasing use of Insulin analogs among Type 2 diabetics. These are genetically altered forms of human insulin that offer more predictable glucose-lowering effects and fewer side effects compared to traditional human insulin.

Despite these advances, the reality remains that many diabetics in Canada have poor glycemic control, highlighting the need for ongoing education and resources to support optimal insulin usage.

As a leading supplier of insulin products in Canada, is dedicated to helping Canadians with diabetes manage their condition effectively. Through their comprehensive selection of insulin products and commitment to providing high-quality diabetes care information, they have become a key partner in Canadian diabetes management. They also offer assistance with product selection and dosage guidelines to help patients achieve the optimal outcomes from their insulin therapy.

Back to top button